Diabetes MellitusDAMPNCT03747471
Conversation Map and Diabetes in Pakistan
A study testing Diabetic Conversation Map in people with Diabetes Mellitus and Diabetes, run by Rubina Qasim at 1 site in Pakistan.
Trial summary
Background Diabetes is recognized as an important cause of premature death and disability. Non-clinical interventions play an important role in the control of diabetes and the prevention of its associated complications. Read more about this study
- Who is it for?
- Ages 30 to 60 years
- Conditions the study is for
- Diabetes Mellitus, Diabetes, Self Efficacy
- What is being tested?
- Diabetic Conversation Map
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Jan 2019to 30 Apr 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- All patients of both gendersage 30-60 years diagnosed with type 2 diabetes mellitusfor at least 5 years, presenting at the diabetes clinics of study setting and considered by health care professional to have a suboptimal management of their disease.
- Patient having HbA1c more than 7 will be included
- Patients who have not participated in any diabetic educational program before.
- Patients who will be found to be diabetes distressed as recommended in diabetes distress (DD) screening tool
Who cannot join
- Patients with major disabilities, diagnosed with mental health problems/ cognitive pattern not intact and those with major diabetes related complications.
- Patients residing outside of Karachi or intended to leave the city during the study duration will be excluded.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Conversation Map on Diabetes Management Self-efficacy and Diabetic Distress Among Type 2DM Patient in Pakistan: A Randomized Controlled Trial
Background Diabetes is recognized as an important cause of premature death and disability. Non-clinical interventions play an important role in the control of diabetes and the prevention of its associated complications. Traditional methods of educating diabetic patients to empower them for the control of their disease might not work in the developing world. However, the novel interactive and pictorial health education tool named Diabetes Conversation Map (DCM) might be effective for the improvement of diabetes management self-efficacy and distress among diabetic patients in lower middle income setting of Karachi, Pakistan.
Objective To assess the effectiveness of DCM as compared to routine care to improve the diabetes management self-efficacy (DMSE) and diabetic distress (DD) among type 2 diabetic patients (T2DM) visiting diabetic clinics of tertiary care hospitals in lower middle income setting of Karachi, Pakistan.
Methodology This will be a two arms randomized controlled trial, conducted in two tertiary care hospitals, Karachi. A sample of 120 T2DM patients of age 30 - 60 years with sub-optimal diabetes control will be screened through eligibility criteria and diabetes distress screening tool. Patients who fulfill the eligibility criteria and have diabetes distress will be randomized into intervention (n=60) and control group (n=60) using sealed envelopes. The intervention arm will receive four diabetic education sessions using the DCM in a group of 5-8 participants and each session will be at the interval of one (1) week, by the principal investigator. T2DM patients in the controlled arm will receive routine care. Data on DMSE and DD will also be measured 2-3 months post intervention after the completion of all education sessions. Descriptive statistics will be used for data analysis through SPSS version 20; whereas, application of Repeated Measures ANOVA will be carried out for inferential statistics.
Read the detailed description
Like any other chronic disease, the control of diabetes is very essential. Non-clinical interventions such as life style modification, stress relief and healthy dietary habits have been proven to be effective against the control of diabetes and prevention of diabetes related complications. Traditionally, diabetic patients used to receive education related to their disease process, metabolic control, exercise and diabetic diet through didactic lectures, brochures, pamphlets, and face to face counseling. While these traditional methods are found to be effective in diabetes self-management in the western world due to better literacy rate, level of understanding and access to modern modes of communications. However, in the developing world these methods could not work because of several reasons including poor literacy. Among novel methods, Diabetes Conversation Maps are considered as useful tools for the educational empowerment of diabetic patients. These are interactive pictorial tools designed in such a way that it does not need formal education for common understanding. In developing countries like Pakistan, where the literacy rate is very less, these tools might prove to be effective for the control of diabetes and its associated complications. Diabetes conversation maps have been used and tested in several countries predominantly in the developed world. In the developing region, while it has shown some impact during the observational studies, literature generated from randomized control trials is still limited. Patients in the developing region has different level of education and environmental exposures such as access to internet and social media, they have different socio-demographic characteristics and hence might behave differently from their counterparts in the developed world. Therefore, there is a need of well-designed randomized controlled trial to evaluate the effectiveness of Diabetes Conversation Map versus routine diabetic care in DMSE and DD in a low middle income setting of Karachi, Pakistan.
Research Question Is effectiveness of DCM as an educational tool same as routing care for improving the DMSE and DD in patients with T2DM visiting diabetic clinic of a tertiary care hospital in Karachi, Pakistan? 1.2 Significance of study: This study is a pioneer effort for generating new knowledge about the use of Diabetes Conversation Map. Findings of this study will be helpful for the nursing leadership and organizational leadership for use of Diabetes Conversation Map for managing the risks factors / complications of the DM. Also, it is cost effective intervention to be implemented by the health professionals, resulting in saving patients from managing DM, its complications, money and time. Moreover, findings of this study will be available for Pakistan Nursing Council (PNC) and Pakistan Medical and Dental Council (PMDC), for inculcating it into the curricula.
1.3 Hypothesis 1.3.1. H0: The effectiveness of DCM as educational tool is same to routine diabetic education among patients with diabetes type 2 (T2DM) visiting diabetic clinic in a tertiary care hospital of Karachi, Pakistan.
1.3.2. Ha: The effectiveness of DCM as educational tool is different to routine diabetic education among patients with diabetes type 2 (T2DM) visiting diabetic clinic in a tertiary care hospital of Karachi, Pakistan.
1.4 Objective of the study The objective of this study is to assess the effectiveness of DCM as an educational tool in comparison to routine care for improving the DMSE and DD among patients with type 2 diabetes mellitus visiting diabetic clinic of tertiary care hospital in Karachi, Pakistan.
1.5 Operational definitions
T2 Diabetes mellitus:
Type 2 diabetes is a metabolic condition where body develops resistance for insulin by progressive beta-cell dysfunction.
Diabetes control:
Patients with type 2 diabetes mellitus having HbA1c≤7
Diabetic Management Self-Efficacy (DMSE):
Patient level of confidence and believe that they can perform diabetes management activities such as, eat control diet, monitoring of blood glucose, administration of insulin/timely intake of oral medication , medical checkup, daily exercise in routine life in spite of challenging circumstances.
Suboptimal control of diabetes:
HbA1c is a clinical indicator, which shows how well diabetes is controlled for the last 3 months. HbA1c level more than 7 % will be considered suboptimal control of diabetes
Diabetes distress (DD):
Patient Experiences trouble and invisible emotional burdens, when managing a severe chronic disease like diabetes.
METHODOLOGY 1.1 Study Design: Randomized controlled trial 1.2 Study setting: This study will be conducted in National Institute of Diabetes and Endocrinology (NIDE) Ojha campus Dow University of Health Sciences (DUHS).
1.3 Study duration: Duration for the study will be one year after the final approval of synopsis. 1.4 Sample size A study from China (41) reported mean DDS score of control and intervention group at baseline as 32.77±14.57 and 26.08±9.92 respectively. After intervention the respective scores were 22.79±4.95 and 30.09±12.14. Using these estimates, 95% confidence interval and 80% power of the test, the computed sample size was 88, 44 in each group. After adding attrition rate, a total of 120 subjects i.e. 60 in control arm and 60 in intervention arm will be included in the study. Since there are two hospitals, 30 participants in each group will be included from each hospital.
1.5 Sampling technique Individual randomization will be done by opening the sealed envelopes for the allocation of intervention. There will be 120 sealed opaque envelopes containing either diabetes conversation map (acronym DCM; n=60) or routine care (acronym RC; n=60). These envelopes will be shuffled and opened for each eligible participant.
1.6 Data collection The principle investigator (PI) will take permission from related authority. The PI will be sitting in the waiting area outside the clinic where the physician will refer all the patients diagnosed with T2 diabetes with suboptimal management. After screening based on eligibility criteria, informed consent will be taken. Structured Questionnaire will be used for collecting demographic, clinical, and laboratory data.
After 3 months of enrollment, a follow up interview will be conducted using a structured questionnaire and blood test for HbA1c to see the change in baseline measurements across the two groups.
1.7 Intervention arm The intervention arm will receive 4 sessions based on diabetes conversation maps. These sessions will be conducted 1 week apart (45-60min) in a group of 5-8 participants per group. These sessions will be facilitated by a trained educator. These sessions will include topics on managing diabetes, following a healthy lifestyle, starting insulin, and experiencing life with diabetes.
Conversation Map (CM) education tools are a series of tools for facilitated group education 5-8 that were developed by Healthy Interactions in collaboration with the International Diabetes Federation (IDF) and are sponsored by Lilly Diabetes.
CM-based education guides people with diabetes through a process with the aim of helping them understand and internalize information about their disease and generate insightful conclusions, which may then result in improved self-management decisions and actions.
1.8 Control Arm In control group, participants will attend their routine regular appointments to health care professional and receive instruction provided as part of routine care during the study period.
1.9 Ethical concerns Approval for ethical consideration will be taken from Institutional Review Board of DUHS. Written inform Consent will be taken from all the participants including permission to access their medical records. No individual information of study participants and organization will be published as the data and results published will be in aggregate form for maintaining the confidentiality of the study participants and organization. All the information about the study participants will be kept in lock and key.
1.10 Study Variables:
Dependent variables:
Diabetes Management Self-Efficacy (DMSE) and Diabetes Distress (DD) and HbA1c are dependent variable in this study.
Independent variables:
This will include age, gender, BMI, education level, occupation, marital status, time since diabetes diagnosis, time since diabetes treatment, type of treatment for Diabetes e.g. Tablets, insulin etc. use of smart phones, use of internet and monthly income.
1.11 Statistical Analysis: All statistical analysis will be performed using SPSS version 20. Intention to treat and per protocol analysis will be performed. Descriptive statistics will be reported by computing frequencies and percentages for categorical variables and means, standard deviation and ranges (minimum and maximum) values for continuous variables. Outcome variables will be calculated by summing the scores of respective scales. Repeated Measures ANOVA will be used to measure difference in HbA1C, DMSE and DDS between intervention and control arm. Sensitivity analysis will be run to measure effect of any missing observations on outcome of the study.
- Conditions
- Diabetes Mellitus, Diabetes, Self Efficacy, Diabetes Mellitus, Type 2
- Being tested
- Diabetic Conversation Map
- Keywords
- Diabetes, Type 2 Diabetes mellitus, Health Education, Conversation Map, Developing countries
- Medical subject headings
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Health Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Diabetic Conversation MapBehavioural
Diabetic Conversation Map education tools are a series of tools for facilitated group education 5-8that were developed by Healthy Interactions in collaboration with the International Diabetes Federation (IDF) and are sponsored by Lilly Diabetes.
CM-based education guides people with diabetes through a process with the aim of helping them understand and internalize information about their disease and generate insightful conclusions, which may then result in improved self-management decisions and actions.
| Study group | Role | What they receive |
|---|---|---|
| Experimental Arm | Experimental | Intervention: Diabetic Conversation Map x 4 Sessions Receives: Behavioral: Diabetic Conversation Map |
| Control Arm | No intervention | No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline Diabetes Management Self-Efficacy (DMSE) at 3 months:
The change in DMSE will be measured using validated DMSE scale. The scale has 20 items comprised of 4 domains; 1) nutrition specific and weight, 2) medical treatment, 3) physical exercise, 4) blood sugar. Each item is scored on 11 point likert scale (0=completely unable to 10=completely able). Possible score ranges from 0 to 200, with higher score representing higher self-efficacy.
Measured: at baseline and after 3 months of enrollment
Change from baseline Diabetes distress (DD) 3 months:
The change in DD will be screened using validated DD scale. The scale has two parts; part 1 is consisting of two items asking about feelings of overburden due to demands of living with diabetes and feelings of failure with diabetes routine; the aim of part 1 is to screen for the presence of DD. Part 1 will be administered before the enrollment of the patient to screen for the presence of DD. If DD is present, part 2 will begin consisting of 17 items to score the extent of DD. Each item is scored on a likert scale ranging from 1 (not a problem) to 6 (a very serious problem). According to the instructions of DDS scoring sheet, total DDS will be measured with mean score while dividing the sum of all items by 17.The mean score of ≥3 will be the threshold for being distressed.
Measured: baseline and 3 months of enrollment
Secondary outcomes (1)
Change from baseline HbA1C at 3 months:
Change in HbA1c level will be measured at baseline and 3 months after enrollment to see mean difference in the two measurements
Measured: baseline and 3 months after enorllment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Nov 2018
- Study start1 Jan 2019
- Primary completion1 Feb 2019
- Study completion30 Apr 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Diabetes MellitusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This will be a 2 arms individual randomized controlled trial. Intervention arm will receive teaching from the nurses using diabetic conversation map with visual images and control arm will receive teaching from the nurses using the traditional diabetic counselling.
- Masking
- None (open label)
- Enrolment
- 120 participants (actual)
Sponsor and investigators
- Lead sponsor
- Rubina Qasim
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Rubina Qasim, Dow University of Health Sciences
- Investigators
- Rubina Qasim, MSc, Principal investigator, Dow University of Health Sciences, Ojha Campus
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03747471
- Sponsor's protocol ID
- ruby1234
- Acronym
- DAMP
- Status last verified
- Jul 2019
- First submitted
- 13 Nov 2018
- Last updated
- 17 Jul 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Qasim R, Masih S, Yousafzai MT, Shah H, Manan A, Shah Y, Yaqoob M, Razzaq A, Khan A, Rohilla ARK. Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial. BMC Endocr Disord. 2020 Jun 16;20(1):88. doi: 10.1186/s12902-020-00572-x.
PubMed 32546240Qasim R, Masih S, Hussain M, Ali A, Khan A, Shah Y, Shah H, Yousafzai MT. Effect of diabetic counseling based on conversation map as compared to routine counseling on diabetes management self-efficacy and diabetic distress among patients with diabetes in Pakistan: a randomized controlled trial (study protocol). BMC Public Health. 2019 Jul 8;19(1):907. doi: 10.1186/s12889-019-7266-3.
PubMed 31286927
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Conversation Map on Diabetes Management Self-efficacy and Diabetic Distress Among Type 2DM Patient in Pakistan: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT03747471
- Acronym / sponsor ID
- DAMP / ruby1234
- Conditions
- Diabetes Mellitus, Diabetes, Self Efficacy, Diabetes Mellitus, Type 2
- Keywords
- Diabetes, Type 2 Diabetes mellitus, Health Education, Conversation Map, Developing countries
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 120 participants (actual)
- Lead sponsor
- Rubina QasimUniversity, hospital or other
- Study start
- 1 Jan 2019 (actual)
- Primary completion
- 1 Feb 2019 (actual)
- Study completion
- 30 Apr 2019 (actual)
- First posted
- 20 Nov 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background Diabetes is recognized as an important cause of premature death and disability. Non-clinical interventions play an important role in the control of diabetes and the prevention of its associated complications. Traditional methods of educating diabetic patients to empower them for the control of their disease might not work in the developing world. However, the novel interactive and pictorial health education tool named Diabetes Conversation Map (DCM) might be effective for the improvement of diabetes management self-efficacy and distress among diabetic patients in lower middle income setting of Karachi, Pakistan.
Objective To assess the effectiveness of DCM as compared to routine care to improve the diabetes management self-efficacy (DMSE) and diabetic distress (DD) among type 2 diabetic patients (T2DM) visiting diabetic clinics of tertiary care hospitals in lower middle income setting of Karachi, Pakistan.
Methodology This will be a two arms randomized controlled trial, conducted in two tertiary care hospitals, Karachi. A sample of 120 T2DM patients of age 30 - 60 years with sub-optimal diabetes control will be screened through eligibility criteria and diabetes distress screening tool. Patients who fulfill the eligibility criteria and have diabetes distress will be randomized into intervention (n=60) and control group (n=60) using sealed envelopes. The intervention arm will receive four diabetic education sessions using the DCM in a group of 5-8 participants and each session will be at the interval of one (1) week, by the principal investigator. T2DM patients in the controlled arm will receive routine care. Data on DMSE and DD will also be measured 2-3 months post intervention after the completion of all education sessions. Descriptive statistics will be used for data analysis through SPSS version 20; whereas, application of Repeated Measures ANOVA will be carried out for inferential statistics.
Detailed description
Like any other chronic disease, the control of diabetes is very essential. Non-clinical interventions such as life style modification, stress relief and healthy dietary habits have been proven to be effective against the control of diabetes and prevention of diabetes related complications. Traditionally, diabetic patients used to receive education related to their disease process, metabolic control, exercise and diabetic diet through didactic lectures, brochures, pamphlets, and face to face counseling. While these traditional methods are found to be effective in diabetes self-management in the western world due to better literacy rate, level of understanding and access to modern modes of communications. However, in the developing world these methods could not work because of several reasons including poor literacy. Among novel methods, Diabetes Conversation Maps are considered as useful tools for the educational empowerment of diabetic patients. These are interactive pictorial tools designed in such a way that it does not need formal education for common understanding. In developing countries like Pakistan, where the literacy rate is very less, these tools might prove to be effective for the control of diabetes and its associated complications. Diabetes conversation maps have been used and tested in several countries predominantly in the developed world. In the developing region, while it has shown some impact during the observational studies, literature generated from randomized control trials is still limited. Patients in the developing region has different level of education and environmental exposures such as access to internet and social media, they have different socio-demographic characteristics and hence might behave differently from their counterparts in the developed world. Therefore, there is a need of well-designed randomized controlled trial to evaluate the effectiveness of Diabetes Conversation Map versus routine diabetic care in DMSE and DD in a low middle income setting of Karachi, Pakistan.
Research Question Is effectiveness of DCM as an educational tool same as routing care for improving the DMSE and DD in patients with T2DM visiting diabetic clinic of a tertiary care hospital in Karachi, Pakistan? 1.2 Significance of study: This study is a pioneer effort for generating new knowledge about the use of Diabetes Conversation Map. Findings of this study will be helpful for the nursing leadership and organizational leadership for use of Diabetes Conversation Map for managing the risks factors / complications of the DM. Also, it is cost effective intervention to be implemented by the health professionals, resulting in saving patients from managing DM, its complications, money and time. Moreover, findings of this study will be available for Pakistan Nursing Council (PNC) and Pakistan Medical and Dental Council (PMDC), for inculcating it into the curricula.
1.3 Hypothesis 1.3.1. H0: The effectiveness of DCM as educational tool is same to routine diabetic education among patients with diabetes type 2 (T2DM) visiting diabetic clinic in a tertiary care hospital of Karachi, Pakistan.
1.3.2. Ha: The effectiveness of DCM as educational tool is different to routine diabetic education among patients with diabetes type 2 (T2DM) visiting diabetic clinic in a tertiary care hospital of Karachi, Pakistan.
1.4 Objective of the study The objective of this study is to assess the effectiveness of DCM as an educational tool in comparison to routine care for improving the DMSE and DD among patients with type 2 diabetes mellitus visiting diabetic clinic of tertiary care hospital in Karachi, Pakistan.
1.5 Operational definitions
T2 Diabetes mellitus:
Type 2 diabetes is a metabolic condition where body develops resistance for insulin by progressive beta-cell dysfunction.
Diabetes control:
Patients with type 2 diabetes mellitus having HbA1c≤7
Diabetic Management Self-Efficacy (DMSE):
Patient level of confidence and believe that they can perform diabetes management activities such as, eat control diet, monitoring of blood glucose, administration of insulin/timely intake of oral medication , medical checkup, daily exercise in routine life in spite of challenging circumstances.
Suboptimal control of diabetes:
HbA1c is a clinical indicator, which shows how well diabetes is controlled for the last 3 months. HbA1c level more than 7 % will be considered suboptimal control of diabetes
Diabetes distress (DD):
Patient Experiences trouble and invisible emotional burdens, when managing a severe chronic disease like diabetes.
METHODOLOGY 1.1 Study Design: Randomized controlled trial 1.2 Study setting: This study will be conducted in National Institute of Diabetes and Endocrinology (NIDE) Ojha campus Dow University of Health Sciences (DUHS).
1.3 Study duration: Duration for the study will be one year after the final approval of synopsis. 1.4 Sample size A study from China (41) reported mean DDS score of control and intervention group at baseline as 32.77±14.57 and 26.08±9.92 respectively. After intervention the respective scores were 22.79±4.95 and 30.09±12.14. Using these estimates, 95% confidence interval and 80% power of the test, the computed sample size was 88, 44 in each group. After adding attrition rate, a total of 120 subjects i.e. 60 in control arm and 60 in intervention arm will be included in the study. Since there are two hospitals, 30 participants in each group will be included from each hospital.
1.5 Sampling technique Individual randomization will be done by opening the sealed envelopes for the allocation of intervention. There will be 120 sealed opaque envelopes containing either diabetes conversation map (acronym DCM; n=60) or routine care (acronym RC; n=60). These envelopes will be shuffled and opened for each eligible participant.
1.6 Data collection The principle investigator (PI) will take permission from related authority. The PI will be sitting in the waiting area outside the clinic where the physician will refer all the patients diagnosed with T2 diabetes with suboptimal management. After screening based on eligibility criteria, informed consent will be taken. Structured Questionnaire will be used for collecting demographic, clinical, and laboratory data.
After 3 months of enrollment, a follow up interview will be conducted using a structured questionnaire and blood test for HbA1c to see the change in baseline measurements across the two groups.
1.7 Intervention arm The intervention arm will receive 4 sessions based on diabetes conversation maps. These sessions will be conducted 1 week apart (45-60min) in a group of 5-8 participants per group. These sessions will be facilitated by a trained educator. These sessions will include topics on managing diabetes, following a healthy lifestyle, starting insulin, and experiencing life with diabetes.
Conversation Map (CM) education tools are a series of tools for facilitated group education 5-8 that were developed by Healthy Interactions in collaboration with the International Diabetes Federation (IDF) and are sponsored by Lilly Diabetes.
CM-based education guides people with diabetes through a process with the aim of helping them understand and internalize information about their disease and generate insightful conclusions, which may then result in improved self-management decisions and actions.
1.8 Control Arm In control group, participants will attend their routine regular appointments to health care professional and receive instruction provided as part of routine care during the study period.
1.9 Ethical concerns Approval for ethical consideration will be taken from Institutional Review Board of DUHS. Written inform Consent will be taken from all the participants including permission to access their medical records. No individual information of study participants and organization will be published as the data and results published will be in aggregate form for maintaining the confidentiality of the study participants and organization. All the information about the study participants will be kept in lock and key.
1.10 Study Variables:
Dependent variables:
Diabetes Management Self-Efficacy (DMSE) and Diabetes Distress (DD) and HbA1c are dependent variable in this study.
Independent variables:
This will include age, gender, BMI, education level, occupation, marital status, time since diabetes diagnosis, time since diabetes treatment, type of treatment for Diabetes e.g. Tablets, insulin etc. use of smart phones, use of internet and monthly income.
1.11 Statistical Analysis: All statistical analysis will be performed using SPSS version 20. Intention to treat and per protocol analysis will be performed. Descriptive statistics will be reported by computing frequencies and percentages for categorical variables and means, standard deviation and ranges (minimum and maximum) values for continuous variables. Outcome variables will be calculated by summing the scores of respective scales. Repeated Measures ANOVA will be used to measure difference in HbA1C, DMSE and DDS between intervention and control arm. Sensitivity analysis will be run to measure effect of any missing observations on outcome of the study.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This will be a 2 arms individual randomized controlled trial. Intervention arm will receive teaching from the nurses using diabetic conversation map with visual images and control arm will receive teaching from the nurses using the traditional diabetic counselling.
| Arm | Type | Receives |
|---|---|---|
| Experimental Arm | Experimental | Behavioral: Diabetic Conversation MapIntervention: Diabetic Conversation Map x 4 Sessions |
| Control Arm | No intervention | –No intervention |
Who may qualify
- Ages
- 30 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- All patients of both gendersage 30-60 years diagnosed with type 2 diabetes mellitusfor at least 5 years, presenting at the diabetes clinics of study setting and considered by health care professional to have a suboptimal management of their disease.
- Patient having HbA1c more than 7 will be included
- Patients who have not participated in any diabetic educational program before.
- Patients who will be found to be diabetes distressed as recommended in diabetes distress (DD) screening tool
Key exclusion criteria (2 listed)
- Patients with major disabilities, diagnosed with mental health problems/ cognitive pattern not intact and those with major diabetes related complications.
- Patients residing outside of Karachi or intended to leave the city during the study duration will be excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Diabetic Conversation MapDiabetic Conversation Map education tools are a series of tools for facilitated group education 5-8that were developed by Healthy Interactions in collaboration with the International Diabetes Federation (IDF) and are sponsored by Lilly Diabetes. CM-based education guides people with diabetes through a process with the aim of helping them understand and internalize information about their disease and generate insightful conclusions, which may then result in improved self-management decisions and actions. | Behavioural | Experimental Arm |
Primary outcome
Change from baseline Diabetes Management Self-Efficacy (DMSE) at 3 months:
Time frame: at baseline and after 3 months of enrollment
The change in DMSE will be measured using validated DMSE scale. The scale has 20 items comprised of 4 domains; 1) nutrition specific and weight, 2) medical treatment, 3) physical exercise, 4) blood sugar. Each item is scored on 11 point likert scale (0=completely unable to 10=completely able). Possible score ranges from 0 to 200, with higher score representing higher self-efficacy.
Change from baseline Diabetes distress (DD) 3 months:
Time frame: baseline and 3 months of enrollment
The change in DD will be screened using validated DD scale. The scale has two parts; part 1 is consisting of two items asking about feelings of overburden due to demands of living with diabetes and feelings of failure with diabetes routine; the aim of part 1 is to screen for the presence of DD. Part 1 will be administered before the enrollment of the patient to screen for the presence of DD. If DD is present, part 2 will begin consisting of 17 items to score the extent of DD. Each item is scored on a likert scale ranging from 1 (not a problem) to 6 (a very serious problem). According to the instructions of DDS scoring sheet, total DDS will be measured with mean score while dividing the sum of all items by 17.The mean score of ≥3 will be the threshold for being distressed.
1 secondary outcome
Change from baseline HbA1C at 3 months:
Time frame: baseline and 3 months after enorllment
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2019.
- Derived from this study: PubMed 32546240Qasim R, Masih S, Yousafzai MT, Shah H, Manan A, Shah Y, Yaqoob M, Razzaq A, Khan A, Rohilla ARK. Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial. BMC Endocr Disord. 2020 Jun 16;20(1):88. doi: 10.1186/s12902-020-00572-x.
- Derived from this study: PubMed 31286927Qasim R, Masih S, Hussain M, Ali A, Khan A, Shah Y, Shah H, Yousafzai MT. Effect of diabetic counseling based on conversation map as compared to routine counseling on diabetes management self-efficacy and diabetic distress among patients with diabetes in Pakistan: a randomized controlled trial (study protocol). BMC Public Health. 2019 Jul 8;19(1):907. doi: 10.1186/s12889-019-7266-3.
- Individual participant dataSharing planned: No
Related trials for Diabetes Mellitus
Active, not recruitingPhase 2
A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease
Diabetic Kidney Disease (DKD), Type 2 Diabetes
Active, not recruitingPhase 3
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Type 1 Diabetes
Recruiting
Culturally Tailored Program for Food-Insecure Adults: SPICE-D
Type 2 Diabetes Mellitus (T2D)
RecruitingPhase 2
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Trauma, Hemorrhage
RecruitingObservational study
Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy
Type 1 Diabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rubina Qasim, MSc principal investigator
Dow University of Health Sciences, Ojha Campus
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Diabetic Conversation Map in people with Diabetes Mellitus and Diabetes, run by Rubina Qasim at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline Diabetes Management Self-Efficacy (DMSE) at 3 months: (time frame: at baseline and after 3 months of enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03747471, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2019.